Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hardha Balachandran
Institutions:
JSS Academy of Higher Education and Research,
JSS College of Pharmacy
Observed institutions:
JSS Academy of Higher Education and Research,
JSS College of Pharmacy
ORCID:
0009-0008-1562-8956
Observed ORCID:
0009-0008-1562-8956
OpenAlex ID:
A5123804682
Quality by design-based development and validation of a robust RP-HPLC method for the simultaneous estimation of nirmatrelvir and ritonavir in pharmaceutical formulations
2025
·
Karthic Murugaiah Pandian
, Subramania nainar Meyyanathan
, et al.
·
Letters in Drug Design & Discovery
·
3
Recent Progress in PARP-1 Inhibitors: Mechanisms, Patent Trends, and Future Directions in Cancer Treatment
2026
·
Hardha Balachandran
, Muskan Sharma
, et al.
·
Recent Patents on Anti-Cancer Drug Discovery
Translational Horizons in Targeted Oncology: Mechanistic Insights, Therapeutic Innovations, and Clinical Impact
2026
·
Hardha Balachandran
, Gowramma Byran
, et al.
·
Current Cancer Drug Targets
Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors: An In Silico Approach
2026
·
Hardha Balachandran
, Kaviarasan Lakshmanan
, et al.
·
Current Computer - Aided Drug Design
Targeting PARP-1 Insights for Inflammatory, Neurological, and Oncologic Therapies
2026
·
Gunavathi Mukesh Kumar
, Hardha Balachandran
, et al.
·
Current Enzyme Inhibition
Design and Evaluation of Naphthoxy and Phenoxy amide as Potential PARP 1 inhibitors: Molecular Docking and In Vitro Analysis
2026
·
Hardha Balachandran
, Subhajit Majumder
, et al.
·
Current Medicinal Chemistry
Heterocyclic Scaffolds in PARP-1 Inhibition: An Emerging Strategy for Targeted Anticancer Therapy
2026
·
Hardha Balachandran
, Gowramma Byran
, et al.
·
Mini-Reviews in Medicinal Chemistry
PARP1 as a Central Node in DNA Repair and Epigenetic Regulation: Implications for Biomarker Discovery and Targeted Therapy in NSCLC
2026
·
Muskan Sharma
, Gowramma Byran
, et al.
·
Mini-Reviews in Medicinal Chemistry
Computational design, synthesis, and in vitro evaluation of thiadiazole-derived PARP-1 inhibitors
2026
·
Hardha Balachandran
, Sowmiya Arun
, et al.
·
Figshare
PARP Inhibitor Resistance Mechanism and Strategies to Overcome Them for More Effective Anti-cancer Treatment
2026
·
Sinjini Das
, Gowramma Byran
, et al.
·
Current Cancer Therapy Reviews
Computational design, synthesis, and in vitro evaluation of thiadiazole-derived PARP-1 inhibitors
2026
·
Hardha Balachandran
, Sowmiya Arun
, et al.
·
Journal of Receptors and Signal Transduction
A Review of the Role of Poly (ADP-Ribose) Polymerase-1 (PARP1) and Its Inhibitors for Cancer Therapy
2026
·
Mettu Omkar Bala Narasimha
, Hardha Balachandran
, et al.
·
Mini-Reviews in Medicinal Chemistry
Show more works
View as search
Works count:
12
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type